AGA Medical Corporation Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	31
ISBN Number	not applicable
Product Code	GMD06823

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a AGA Medical Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Overview
- 2.1 Key Information
- 2.2 Industry Outlook Cardiovascular Devices
3 Major Products and Services
- 3.1 Overview
4 Competitors
5 Key Employees
6 Locations And Subsidiaries
- 6.1 Head Office
7 Recent Developments
- 7.1 Corporate Communications
  - 7.1.1 Jun 20, 2008: AGA Medical Announces Management Changes
  - 7.1.2 Jun 11, 2007: AGA Appoints New CLO
  - 7.1.3 Mar 05, 2007: AGA Appoints VP, Worldwide Sales And Marketing
  - 7.1.4 Oct 02, 2006: AGA Appoints New CFO
- 7.2 Legal and Regulatory
  - 7.2.1 Jun 03, 2008: AGA Agrees To Pay $2 Million Civil Penalty
  - 7.2.2 Jul 31, 2007: AGA Wins Patent Infringement Lawsuit Against Occlutech
- 7.3 Product News
  - 7.3.1 May 16, 2008: AGA Medical Corporation Receives CE Mark Approval For The AMPLATZER Vascular Plug III
  - 7.3.2 Feb 12, 2008: AGA Medical Corporation Receives European CE Mark Approval For The AMPLATZER Duct Occluder II
  - 7.3.3 Sep 10, 2007: AGA Medical Corporation Receives Approval For The AMPLATZER Muscular Ventricular Septal Defect Occluder
  - 7.3.4 Aug 24, 2007: AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
  - 7.3.5 Jul 21, 2006: AGA Medical Announces Enrollment Of First Patients In US Migraine Study
- 7.4 Product Approvals
  - 7.4.1 May 16, 2008: AGA Medical Corporation Receives CE Mark Approval For The AMPLATZER Vascular Plug III
  - 7.4.2 Feb 12, 2008: AGA Medical Corporation Receives European CE Mark Approval For The AMPLATZER Duct Occluder II
  - 7.4.3 Sep 10, 2007: AGA Medical Corporation Receives Approval For The AMPLATZER Muscular Ventricular Septal Defect Occluder
  - 7.4.4 Aug 24, 2007: AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
- 7.5 Clinical Trials
  - 7.5.1 Jul 21, 2006: AGA Medical Announces Enrollment Of First Patients In US Migraine Study
8 AGA Medical Corporation Pipeline Products
- 8.1 AGA Medical Corporation Product Pipeline Analysis
  - 8.1.1 AGA Medical Corporation Pipeline Products By Equipment Type
  - 8.1.2 AGA Medical Corporation Pipeline Products By Development Stage
  - 8.1.3 AGA Medical Corporation Pipeline Products By Therapy Area
  - 8.1.4 AGA Medical Corporation Pipeline Products By Clinical Trials
  - 8.1.5 AGA Medical Corporation Pipeline Products By News Summary
- 8.2 AMPLATZER Duct Occluder II
  - 8.2.1 Product Description
  - 8.2.2 Product Status
  - 8.2.3 Clinical Trials
  - 8.2.4 Product Milestone
- 8.3 AMPLATZER Vascular Plug III
  - 8.3.1 Product Description
  - 8.3.2 Product Status
  - 8.3.3 Product Milestone
- 8.4 AMPLATZER PFO Occluder-Cryptogenic strokes
  - 8.4.1 Product Description
  - 8.4.2 Product Status
  - 8.4.3 Clinical Trials
- 8.5 AMPLATZER PFO Occluder-migraine
  - 8.5.1 Product Description
  - 8.5.2 Product Status
  - 8.5.3 Product Patent Details
9 Appendix
- 9.1 Methodology
  - 9.1.1 Coverage
  - 9.1.2 Secondary Research
  - 9.1.3 Primary Research
  - 9.1.4 Expert Panel Validation
- 9.2 Contact Us
- 9.3 About Global Markets Direct
- 9.4 Disclaimer
1 List of Tables
- Table 1: AGA Medical Corporation,Key Facts
- Table 2: AGA Medical Corporation, Key Employees,
- Table 3: AGA Medical Corporation Pipeline Products by Equipment Type
- Table 4: AGA Medical Corporation Pipeline Products By Development Stage
- Table 5: AGA Medical Corporation Pipeline Products By Therapy Area
- Table 6: AGA Medical Corporation Pipeline Products By Clinical Trials
- Table 7: AGA Medical Corporation Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: AGA Medical Corporation Pipeline Products By Development Stage
- Figure 2: Global Markets Direct Methodology